Gimatecan exerts potent antitumor activity against gastric cancer in vitro and in vivo via AKT and MAPK signaling pathways.
| Image |  |
|---|---|
| Description | scientific article published on 13 December 2017 |
| Author/s | |
| Publication date | December 13, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |